Silver Book Fact

The rate of hospitalization from heart failure before and after transcatheter mitral valve repair (TMVR) decreases 73% (per patient year) in patients at prohibitive surgical risk.

Lim DS, Reynolds MR, Feldman T, et al. Improved Functional Status and Quality of Life in Prohibitive Surgical Risk Patients with Degenerative Mitral Regurgitation After Transcatheter Mitral Valve Repair. J Am Coll Cardiol. 2014; 64(2). https://www.ncbi.nlm.nih.gov/pubmed/24184254

Reference

Title
Improved Functional Status and Quality of Life in Prohibitive Surgical Risk Patients with Degenerative Mitral Regurgitation After Transcatheter Mitral Valve Repair
Publication
J Am Coll Cardiol
Publication Date
2014
Authors
Lim DS, Reynolds MR, Feldman T, et al
Volume & Issue
Volume 64, Issue 2
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Development and widespread use of left ventricular assist devices could result in a 50% decrease in heart failure-related hospitalizations.  
  • Using technologies as treatment for heart disease helps generate cost savings, including a total of $1930 annual savings per person, and a $1.5 billion increased tax revenue  
  • Every $1 spent on technological innovations in heart attack care has produced an estimated $7 gain.  
  • Increased Use of Medicines Reduces Risk of Death After Major Cardiovascular Events: Disease management program increased use of medicines  
  • Between 1980 and 2000, stroke mortality rates fell from 96.2 to 60.8 per 100,000 persons.